tiprankstipranks
Vaxcyte, Inc. (PCVX)
NASDAQ:PCVX
US Market

Vaxcyte (PCVX) Income Statement

Compare
259 Followers

Vaxcyte Income Statement

Last quarter (Q3 2024), Vaxcyte's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Vaxcyte's net income was $-103.12M. See Vaxcyte’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -75.00M$ -9.20M$ -1.80M$ -1.41M$ -1.23M
Operating Expenses
$ 468.04M$ 207.33M$ 102.08M$ 87.10M$ 53.92M
Depreciation and Amortization
$ 3.16M$ 9.20M$ 1.80M$ 1.41M$ 1.23M
EBITDA
$ -464.88M$ -214.29M$ -98.28M$ -87.81M$ -49.00M
Operating Income
$ -468.04M$ -232.26M$ -103.67M$ -89.58M$ -54.15M
Other Income/Expenses
$ 65.78M$ 8.77M$ 3.59M$ 364.00K$ 3.88M
Pretax Income
$ -402.27M$ -223.49M$ -100.08M$ -89.22M$ -50.27M
Net Income
$ -402.27M$ -239.64M$ -100.08M$ -87.82M$ -53.50M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -4.14$ -3.69$ -1.93$ -1.72$ -1.09
Diluted EPS
$ -4.14$ -3.69$ -1.93$ -1.72$ -1.09
Weighted Average Shares Outstanding
97.16M 64.88M 51.92M 51.07M 48.86M
Weighted Average Shares Outstanding (Diluted)
97.16M 64.88M 51.92M 51.07M 48.86M
Currency in USD

Vaxcyte Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis